Security key
86150R107
Stoke Therapeutics, Inc. - Common Stock, $0.0001 par value per share (STOK)
CUSIP: 86150R107
Q3 2024 13F Holders as of 30 Sep 2024
- Type / Class
- Equity / Common Stock, $0.0001 par value per share
- Shares outstanding
- 58,810,778
- Total 13F shares
- 58,214,468
- Share change
- -3,319,199
- Total reported value
- $715,466,637
- Put/Call ratio
- 524%
- Price per share
- $12.29
- Number of holders
- 116
- Value change
- -$45,762,031
- Number of buys
- 58
- Number of sells
- 55
Report period
Q3 2024
Institutions
116
Top holders
10
STOK full security history
Newer quarter: Q4 2024
Previous quarter: Q2 2024
Stoke Therapeutics, Inc. SEC filings
Stoke Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 86150R107
Recent filing periods:
Top shareholders of STOK - Stoke Therapeutics, Inc. - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Skorpios Trust |
13F
|
Company |
18%
|
10,843,681
|
$146,498,130 | — | 30 Jun 2024 | |
| BlackRock Finance, Inc. |
13F
|
Company |
9.2%
|
5,409,169
|
$73,077,872 | — | 30 Jun 2024 | |
| Lynx1 Capital Management LP |
13F
|
Company |
8.8%
|
5,185,191
|
$70,051,931 | — | 30 Jun 2024 | |
| Redmile Group, LLC |
13F
|
Company |
8%
|
4,721,054
|
$63,781,440 | — | 30 Jun 2024 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
7.4%
|
4,368,443
|
$59,017,665 | — | 30 Jun 2024 | |
| RTW INVESTMENTS, LP |
13F
|
Company |
7.2%
|
4,224,838
|
$57,077,561 | — | 30 Jun 2024 | |
| MORGAN STANLEY |
13F
|
Company |
5.9%
|
3,478,797
|
$46,998,549 | — | 30 Jun 2024 | |
| COWEN AND COMPANY, LLC |
13F
|
Company |
5.7%
|
3,365,744
|
$45,471,201 | — | 30 Jun 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
4.6%
|
2,687,658
|
$36,310,260 | — | 30 Jun 2024 | |
| STATE STREET CORP |
13F
|
Company |
2.7%
|
1,591,743
|
$21,504,448 | — | 30 Jun 2024 | |
| Assenagon Asset Management S.A. |
13F
|
Company |
2.5%
|
1,468,202
|
$19,835,409 | — | 30 Jun 2024 | |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND |
13F
|
Company |
2.4%
|
1,387,200
|
$18,741,072 | — | 30 Jun 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
2.3%
|
1,367,517
|
$18,475,155 | — | 30 Jun 2024 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
2.1%
|
1,216,200
|
$16,430,862 | — | 30 Jun 2024 | |
| MARSHALL WACE, LLP |
13F
|
Company |
2%
|
1,161,037
|
$15,685,610 | — | 30 Jun 2024 | |
| Logos Global Management LP |
13F
|
Company |
1.8%
|
1,050,000
|
$14,185,500 | — | 30 Jun 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.4%
|
794,170
|
$10,731,632 | — | 30 Jun 2024 | |
| Granahan Investment Management, LLC |
13F
|
Company |
1%
|
598,401
|
$8,084,398 | — | 30 Jun 2024 | |
| Invesco Ltd. |
13F
|
Company |
0.74%
|
437,136
|
$5,905,708 | — | 30 Jun 2024 | |
| Cormorant Asset Management, LP |
13F
|
Company |
0.73%
|
427,163
|
$5,770,972 | — | 30 Jun 2024 | |
| FMR LLC |
13F
|
Company |
0.68%
|
398,019
|
$5,377,237 | — | 30 Jun 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.49%
|
289,264
|
$3,907,957 | — | 30 Jun 2024 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.49%
|
289,067
|
$3,905,295 | — | 30 Jun 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.48%
|
282,615
|
$3,818,129 | — | 30 Jun 2024 | |
| Birchview Capital, LP |
13F
|
Company |
0.36%
|
210,000
|
$2,837,100 | — | 30 Jun 2024 | |
| DAFNA Capital Management LLC |
13F
|
Company |
0.35%
|
207,427
|
$2,802,339 | — | 30 Jun 2024 | |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC |
13F
|
Company |
0.34%
|
198,280
|
$2,678,763 | — | 30 Jun 2024 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.33%
|
191,360
|
$2,584,693 | — | 30 Jun 2024 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.32%
|
187,351
|
$2,531,112 | — | 30 Jun 2024 | |
| Trexquant Investment LP |
13F
|
Company |
0.31%
|
179,613
|
$2,426,572 | — | 30 Jun 2024 | |
| Sio Capital Management, LLC |
13F
|
Company |
0.3%
|
175,301
|
$2,368,317 | — | 30 Jun 2024 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
0.24%
|
143,636
|
$1,940,523 | — | 30 Jun 2024 | |
| SILVERARC CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.24%
|
141,518
|
$1,911,908 | — | 30 Jun 2024 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.23%
|
137,010
|
$1,851,005 | — | 30 Jun 2024 | |
| Walleye Capital LLC |
13F
|
Company |
0.22%
|
126,830
|
$1,713,473 | — | 30 Jun 2024 | |
| Palo Alto Investors LP |
13F
|
Company |
0.21%
|
125,861
|
$1,700,382 | — | 30 Jun 2024 | |
| UBS Group AG |
13F
|
Company |
0.2%
|
118,254
|
$1,597,612 | — | 30 Jun 2024 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.2%
|
115,892
|
$1,565,701 | — | 30 Jun 2024 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.2%
|
114,905
|
$1,552,367 | — | 30 Jun 2024 | |
| Woodline Partners LP |
13F
|
Company |
0.17%
|
100,182
|
$1,353,459 | — | 30 Jun 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.17%
|
97,798
|
$1,321,251 | — | 30 Jun 2024 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0.17%
|
97,798
|
$1,321,251 | — | 30 Jun 2024 | |
| GILDER GAGNON HOWE & CO LLC |
13F
|
Company |
0.15%
|
88,577
|
$1,196,675 | — | 30 Jun 2024 | |
| Rafferty Asset Management, LLC |
13F
|
Company |
0.14%
|
79,885
|
$1,079,246 | — | 30 Jun 2024 | |
| Fort Point Capital Partners LLC |
13F
|
Company |
0.13%
|
75,429
|
$1,019,046 | — | 30 Jun 2024 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.13%
|
75,414
|
$1,018,843 | — | 30 Jun 2024 | |
| SG Americas Securities, LLC |
13F
|
Company |
0.12%
|
68,601
|
$927,000 | — | 30 Jun 2024 | |
| LOS ANGELES CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.11%
|
66,765
|
$901,995 | — | 30 Jun 2024 | |
| Swiss National Bank |
13F
|
Company |
0.11%
|
66,400
|
$897,064 | — | 30 Jun 2024 | |
| Eversept Partners, LP |
13F
|
Company |
0.1%
|
61,277
|
$827,852 | — | 30 Jun 2024 |
Institutional Holders of Stoke Therapeutics, Inc. - Common Stock, $0.0001 par value per share (STOK) as of Q3 2024
As of 30 Sep 2024,
Stoke Therapeutics, Inc. - Common Stock, $0.0001 par value per share (STOK) was held by
116 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
58,214,468 shares.
The largest 10 holders included
Skorpios Trust, BlackRock, Inc., Lynx1 Capital Management LP, Redmile Group, LLC, RTW INVESTMENTS, LP, BAKER BROS. ADVISORS LP, MORGAN STANLEY, COWEN AND COMPANY, LLC, VANGUARD GROUP INC, and STATE STREET CORP.
This page lists
116
institutional shareholders reporting positions in this security
for the Q3 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2024 vs Q2 2024 Across Filers
Q2 2024 holders
114
Q3 2024 holders
116
Holder diff
2
| Investor | Q2 2024 Shares | Q3 2024 Shares | Share Diff | Share Chg % | Q2 2024 Value $ | Q3 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.